ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
27 November 2023 - 2:00PM
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of
Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that
management will be participating in The Benchmark Company’s 12th
Annual Discovery One-on-One Investor Conference being held
Thursday, December 7, 2023 at the New York Athletic Club in New
York City. Management will be holding one-on-one meetings with
investors.
To schedule a one-on-one meeting with ENDRA, you may submit your
request online via the link provided upon registration. To register
for the conference, please click here.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced
UltraSound (TAEUS®), a ground-breaking technology which
characterizes tissue similar to an MRI, but at 1/50th the cost and
at the point of patient care. TAEUS® is designed to work in concert
with the more than 700,000 ultrasound systems in use globally
today. TAEUS® is initially focused on the measurement of fat in the
liver as a means to assess and monitor steatotic liver disease
(SLD) (formerly known as NAFLD-NASH), a chronic liver disease
spectrum that affects over two billion people globally, and for
which there are no practical diagnostic tools. Beyond the liver,
ENDRA is exploring several other clinical applications of TAEUS®,
including visualization of tissue temperature during energy-based
surgical procedures. For more information, please visit
www.endrainc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231127536287/en/
Company Contact: Irina Pestrikova Senior Director,
Finance investors@endrainc.com www.endrainc.com
Investor Relations Contact: Yvonne Briggs LHA Investor
Relations (310) 691-7100 ybriggs@lhai.com
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024